Article
Liquid biopsy maker Nucleix rakes in $55M to develop blood tests to detect lung cancer early
Rating:
0.0
Views:
123
Likes:
1
Library:
1
It's full steam ahead for Nucleix's blood test for lung cancer detection, thanks to an influx of cash in the Israeli company's latest round of funding. The liquid biopsy maker closed its oversubscribed $55 million financing on April 7, with RA Capital Management leading the round.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value